US EditionInsider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) Director Sells 20,000 Shares of Stock
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Insider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) Director Sells 20,000 Shares of Stock
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Wendall Wierenga sold 20,000 shares of the company’s stock in a transaction on Monday, April 21st. The stock was sold at an average price of $38.46, for a total transaction of $769,200.00. Following the completion of the transaction, the director now directly owns 24,848 shares of the […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
